DoubleTwist Announces New Customers, Realigned Management Team.Business Editors/Health & Medical Writers OAKLAND, Calif.--(BW HealthWire)--Jan. 22, 2002 DoubleTwist, Inc. today announced the following new and renewing customers for its genomic genomic pertaining to a genome. genomic clone see clone. genomic DNA the DNA sequences making up the genome of an individual. genomic library see gene bank. databases and tools: -- Athersys, Inc., SCRAS (a Beaufour Ipsen company), DeveloGen AG and Elan Pharmaceuticals, Inc. have licensed DoubleTwist's GenomeZone(TM) online service. -- ExonHit Therapeutics SA has licensed the Prophecy(TM) database and tools suite, the Prophecy ToolKit and the Genomatix Promoter Resource(TM) database. -- Chiron Corporation has renewed its subscription to the Prophecy suite and also licensed the Prophecy ToolKit. -- A major U.S. pharmaceutical company has licensed DoubleTwist's Clustering and Alignment Tools (CAT). The company also announced that Robert Williamson Robert Williamson is the first name of several notable individuals:
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , has been appointed President and Chief Executive Officer and member of the Board of Directors. John Couch John Couch may refer to:
"We are delighted that market acceptance for our annotated genomic data continues to accelerate and that we now have more than 10 customers for our latest offering, the GenomeZone online service," said Mr. Williamson. "Further, we are pleased to announce that Chiron, the first customer for our annotated human genome The human genome is the genome of Homo sapiens, which is composed of 24 distinct pairs of chromosomes (22 autosomal + X + Y) with a total of approximately 3 billion DNA base pairs containing an estimated 20,000–25,000 genes. database, has renewed its subscription and purchased additional software to maximize its investment in our products. We welcome these new customers that have helped us achieve a record year of revenues in 2001, giving all of us here at DoubleTwist a tremendous sense of accomplishment in this challenging economic environment." "Through its DATAS technology, ExonHit identifies genes that are deregulated in pathologies during the RNA splicing RNA splicing n. See splicing. RNA splicing, n the process by which base pairs that interrupt the continuity of genetic information in deoxyribonucleic acid are removed from the precursors of messenger process. The Prophecy Prophecy See also Omen. Prosperity (See SUCCESS.) Ancaeus prophecy that he would not live to taste the wine from his vineyards is fulfilled. [Gk. Myth. suite provides a safe, behind the firewall solution to integrate and mine our libraries with genomic data and annotations in a synthetic and user-friendly manner," said Laurent Bracco, Executive VP, Research, ExonHit Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. . "DoubleTwist has recently implemented a number of restructuring measures to enhance our competitive position in the marketplace," said Couch. "Robert Williamson has been instrumental in leading these operational improvements, and I am pleased to turn over the Chief Executive role to him to lead this new era for the company. The Board and investors are fully behind the management realignment re·a·lign tr.v. re·a·ligned, re·a·lign·ing, re·a·ligns 1. To put back into proper order or alignment. 2. To make new groupings of or working arrangements between. and we look forward to achieving our goals in 2002." DoubleTwist, Inc. is an innovator in the application of information technology to the life sciences. The Company provides genomic databases and bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the software for drug discovery and related life science disciplines. DoubleTwist's strategy is to continue to develop its proprietary technology platform and new products aimed at facilitating a systems approach to biological research. For more information, contact DoubleTwist, Inc. at 510/628-0100 or e-mail info-pr@doubletwist.com or visit http://www.doubletwist.com. Note to Editors: DoubleTwist, GenomeZone, Prophecy and the DoubleTwist logo are trademarks of DoubleTwist, Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion